”We close another strong quarter and grow organically by 4,0%, supported by a solid order intake. We successfully navigate the Covid-19 challenges and see a continued recovery within profitable categories like patient handling, service and DVT. Our profitability continues to improve and we report an adjusted EBITDA-margin exceeding 23% for the first time,” says Joacim Lindoff, President & CEO.

“The implementation of our long-term strategy continues with full force, at the same time as we are delivering on our short-term targets. Our newly launched SEM scanner is generating high interest and we currently have more than 150 evaluations planned or completed by customers around the world. In summary, we add a strong quarter to the books and maintain a positive outlook for our performance over the coming quarters,” concludes Joacim Lindoff.

April-June 2021 in brief

• Net sales amounted to SEK 2,199 M (2,264).
  Net sales grew organically by 4.0%.
• Adjusted EBITDA increased 4.9% to SEK 513 M (489).
  In comparable currencies, profit was SEK 546 M, corresponding to an improvement of about 12%.
• Adjusted operating profit increased by 12.8% to SEK 275 M (244).
  In comparable currencies, profit was SEK 295 M, corresponding to an improvement of about 21%.
• Profit after financial items increased to SEK 253 M (152).
• Earnings per share rose to SEK 0.70 (0.42).
• Cash flow from operations amounted to SEK 431 M (613).
• Acquisition of South African rental operations specializing in pressure injury prevention.

Telephone conference

Fund managers, analysts and the media are invited to a teleconference on July 15 at 08.00 CET. Please see details below to join the conference:

Sweden: +46 8 505 583 59

USA: +1 646 722 4956

UK: +44 333 300 9265

A presentation will be held during the telephone conference. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q2-2020

Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2021/

A recording of the teleconference will be available for 90 days via the following link: https://tv.streamfabriken.com/arjo-q2-2020

For more information, please contact:

Kornelia Rasmussen
Executive Vice President, Marketing Communications & Public Relations
Tel: +46 (0)10 335 4810
Email: kornelia.rasmussen@arjo.com

Maria Nilsson
Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4866
Email: maria.nilsson@arjo.com

This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on July 15, 2021.
 

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With over 6,000 people worldwide and 60 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com